In ₹ Crore except Per Share Latest Annual | ANTHEM FY26 | SYNGENE FY26 | DIVISLAB FY26 | GLAXO FY26 | Peer Median | |
|---|---|---|---|---|---|---|
| Valuation — at last close | ||||||
| P/E | — | ◆ 48.79× | 97.31× | 52.42× | 52.42× | |
| P/B | 17.27× | ◆ 3.20× | 14.89× | 21.19× | 14.89× +16% | |
| EV/EBITDA | 61.95× | ◆ 16.11× | 72.47× | 35.08× | 35.08× +77% | |
| Market Cap | ₹52,540 Cr | ₹15,471 Cr | ₹2.49L Cr | ₹48,417 Cr | ₹48,417 Cr +9% | |
| Growth | ||||||
| Revenue CAGR 3Y | — | 5.40% | ◆ 10.78% | 5.53% | 5.53% | |
| Revenue CAGR 5Y | — | ◆ 11.35% | 8.67% | 3.62% | 8.67% | |
| Net Income CAGR 3Y | — | -11.98% | 12.09% | ◆ 19.26% | 12.09% | |
| Revenue YoY (latest Q) | -22.58% | -15.84% | ◆ 27.80% | 16.55% | 16.55% -236% | |
| Net Income YoY (latest Q) | -11.67% | -110.38% | ◆ 65.50% | 15.69% | 15.69% -174% | |
| Profitability | ||||||
| EBITDA Margin | ◆ 39.25% | 24.57% | 32.59% | 34.26% | 32.59% +20% | |
| Net Income Margin | ◆ 27.86% | 8.47% | 24.32% | 27.11% | 24.32% +15% | |
| Return on Common Equity | 19.45% | 6.54% | 15.32% | ◆ 45.34% | 15.32% +27% | |
| Return on Capital Employed | 22.55% | 8.46% | 16.55% | ◆ 48.84% | 16.55% +36% | |
| Return on Assets | 17.26% | 4.49% | 12.82% | ◆ 23.96% | 12.82% +35% | |
| Credit & Quality | ||||||
| Total Debt/Equity | 0.02× | ◆ 0.00× | 0.00× | 0.00× | 0.00× | |
| Interest Coverage | 101.50× | 9.54× | 129.48× | ◆ 455.22× | 129.48× -22% | |
| Scale — latest FY | ||||||
| Revenue / Total Income | ₹2,124 Cr | ₹3,739 Cr | ₹10,560 Cr | ₹3,822 Cr | ₹3,822 Cr -44% | |
| Net Income | ₹592 Cr | ₹317 Cr | ₹2,568 Cr | ₹1,036 Cr | ₹1,036 Cr -43% | |
| Total Assets | ₹3,429 Cr | ₹7,055 Cr | ₹20,033 Cr | ₹4,324 Cr | ₹7,055 Cr -51% | |
| EPS | ₹0 | ₹7.87 | ₹96.75 | ₹54.52 | ₹54.52 -100% | |
| Book Value per Share | ₹54.16 | ₹120.11 | ₹632.49 | ₹134.86 | ₹134.86 -60% | |